Aviad Friedman - Net Worth and Insider Trading

Aviad Friedman Net Worth

The estimated net worth of Aviad Friedman is at least $51,261 dollars as of 2024-05-21. Aviad Friedman is the Director of Oramed Pharmaceuticals Inc and owns about 22,191 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $51,261. Details can be seen in Aviad Friedman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Aviad Friedman has not made any transactions after 2018-08-09 and currently still holds the listed stock(s).

Transaction Summary of Aviad Friedman

To

Aviad Friedman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aviad Friedman owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .

Click here to see the complete history of Aviad Friedman’s form 4 insider trades.

Insider Ownership Summary of Aviad Friedman

Ticker Comapny Transaction Date Type of Owner
ORMP Oramed Pharmaceuticals Inc 2018-08-09 director

Aviad Friedman Latest Holdings Summary

Aviad Friedman currently owns a total of 1 stock. Aviad Friedman owns 22,191 shares of Oramed Pharmaceuticals Inc (ORMP) as of August 9, 2018, with a value of $51,261.

Latest Holdings of Aviad Friedman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORMP Oramed Pharmaceuticals Inc 2018-08-09 22,191 2.31 51,261

Holding Weightings of Aviad Friedman


Aviad Friedman Form 4 Trading Tracker

According to the SEC Form 4 filings, Aviad Friedman has made a total of 0 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 2,500 shares on August 9, 2018, which cost Aviad Friedman around $12,375.

Insider Trading History of Aviad Friedman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aviad Friedman Trading Performance

GuruFocus tracks the stock performance after each of Aviad Friedman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aviad Friedman is -13.09%. GuruFocus also compares Aviad Friedman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aviad Friedman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Aviad Friedman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Aviad Friedman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.84
Relative Return to S&P 500(%) 1.21

Aviad Friedman Ownership Network

Ownership Network List of Aviad Friedman

No Data

Ownership Network Relation of Aviad Friedman


Aviad Friedman Owned Company Details

What does Oramed Pharmaceuticals Inc do?

Who are the key executives at Oramed Pharmaceuticals Inc?

Aviad Friedman is the director of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .

Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary

Over the past 18 months, Aviad Friedman made no insider transaction in Oramed Pharmaceuticals Inc (ORMP). Other recent insider transactions involving Oramed Pharmaceuticals Inc (ORMP) include a net purchase of 126,000 shares made by Nadav Kidron , a net sale of 100,000 shares made by Miriam Kidron , and a net purchase of 70,000 shares made by Yadin Rozov .

In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 113,325 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 196,000 shares were bought by its insiders, resulting in a net purchase of 82,675 shares.

Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oramed Pharmaceuticals Inc Insider Transactions

No Available Data

Aviad Friedman Mailing Address

Above is the net worth, insider trading, and ownership report for Aviad Friedman. You might contact Aviad Friedman via mailing address: Hadassa 6, Tel Aviv L3 6451306.

Discussions on Aviad Friedman

No discussions yet.